• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® DRYSEAL FLEX INTRODUCER SHEATH; INTRODUCER, CATHETER Back to Search Results
Catalog Number DSF2033
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Vascular Dissection (3160)
Event Date 04/17/2022
Event Type  Injury  
Event Description
On (b)(6) 2022, a patient underwent emergency endovascular treatment of an infected thoracic aortic aneurysm using a gore® tag® conformable thoracic stent graft with active control system, and a 20fr gore® dryseal flex introducer sheath.During the treatment, the 20fr sheath was inserted from the right external iliac artery.According to the report, resistance was felt when the sheath was inserted into access vessel.The gore® tag® device was successfully implanted, however, a delayed proximal type i endoleak was reportedly observed.No touch up or other further treatment was performed, and the physician elected to monitor the endoleak.After the sheath was removed, decreased blood flow was reportedly observed.An intra-operative angiograph revealed an access vessel dissection.An additional stent graft was implanted to treat the dissection.The procedure was concluded without any further reported complications, and the patient tolerated the procedure.The physician commented that the patient¿s right external iliac artery was both fragile and narrow (measurement not available), and the dissection may have occurred due to sheath insertion maneuvers inside the narrow vessel.
 
Manufacturer Narrative
(b)(4).It should be noted the gore® dryseal flex introducer sheath instructions for use (ifu) state ¿adequate vessel access is required to introduce the sheath into the vasculature.Careful evaluation of vessel size, anatomy, tortuosity, and disease state (including calcification, plaque, and thrombus) is required to ensure successful sheath introduction and subsequent withdrawal.If vessel is not adequate for access, major bleeding, vessel damage, or serious injury to the patient, including death, may result.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® DRYSEAL FLEX INTRODUCER SHEATH
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
damon jackson
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key14381040
MDR Text Key291641177
Report Number3007284313-2022-01907
Device Sequence Number1
Product Code DYB
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K160254
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 05/12/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberDSF2033
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/17/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age80 YR
Patient SexFemale
-
-